Wrong choice of words, my bad. Inconsequential would probably be more appropriate. The dilution effect would not be significant. Granting of FDA triggers Winola contract and I am sure others as well that management would have secured by then. Minimum revenue from this one contract alone is 60m+ AUD. That's larger than our current market cap. The effect of a dilution wouldn't even be a blip on the re-rate.
- Forums
- ASX - By Stock
- GMV
- Ann: G Medical Innovations Investor Presentation
Ann: G Medical Innovations Investor Presentation, page-6
-
- There are more pages in this discussion • 299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.